Literature DB >> 32314178

Role of Insulin Resistance in the Alzheimer's Disease Progression.

Thuy Trang Nguyen1, Qui Thanh Hoai Ta2, Thi Thuy Dung Nguyen3, Thi Thuy Le4, Van Giau Vo5,6.   

Abstract

Recent studies continue to find evidence linking Type 2 diabetes (T2D) with Alzheimer's disease (AD), the most common cause of dementia, a general term for memory loss and other cognitive abilities serious enough to interfere with daily life. Insulin resistance or dysfunction of insulin signaling is a universal feature of T2D, the main culprit for altered glucose metabolism and its interdependence on cell death pathways, forming the basis of linking T2D with AD as it may exacerbate Aβ accumulation, tau hyperphosphorylation and devastates glucose transportation, energy metabolism, hippocampal framework and promulgate inflammatory pathways. The current work demonstrates the basic mechanisms of the insulin resistance mediates dysregulation of bioenergetics and progress to AD as a mechanistic link between diabetes mellitus and AD. This work also aimed to provide a potential and feasible zone to succeed in the development of therapies in AD by enhanced hypometabolism and altered insulin signaling.

Entities:  

Keywords:  Alzheimer’s disease; Glucose; Hypometaboilsm; Type 2 diabetes; Type 3 diabetes insulin

Year:  2020        PMID: 32314178     DOI: 10.1007/s11064-020-03031-0

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  9 in total

Review 1.  Trends in insulin resistance: insights into mechanisms and therapeutic strategy.

Authors:  Mengwei Li; Xiaowei Chi; Ying Wang; Sarra Setrerrahmane; Wenwei Xie; Hanmei Xu
Journal:  Signal Transduct Target Ther       Date:  2022-07-06

Review 2.  Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer's Disease.

Authors:  Angeles Vinuesa; Carlos Pomilio; Amal Gregosa; Melisa Bentivegna; Jessica Presa; Melina Bellotto; Flavia Saravia; Juan Beauquis
Journal:  Front Neurosci       Date:  2021-04-23       Impact factor: 4.677

3.  Evaluation of Antidiabetic Properties of Adenosma Bracteosum Bonati Extracts in Mice with Streptozotocin-Induced Diabetes.

Authors:  Giau Van Vo; Paul C Guest; Ngoc Hong Nguyen
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Type 3 Diabetes and Its Role Implications in Alzheimer's Disease.

Authors:  Thuy Trang Nguyen; Qui Thanh Hoai Ta; Thi Kim Oanh Nguyen; Thi Thuy Dung Nguyen; Vo Van Giau
Journal:  Int J Mol Sci       Date:  2020-04-30       Impact factor: 5.923

Review 5.  Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment.

Authors:  Shan Liu; Jiguo Gao; Mingqin Zhu; Kangding Liu; Hong-Liang Zhang
Journal:  Mol Neurobiol       Date:  2020-08-23       Impact factor: 5.590

6.  2-Dodecyl-6-Methoxycyclohexa-2,5-Diene-1,4-Dione Ameliorates Diabetic Cognitive Impairment Through Inhibiting Hif3α and Apoptosis.

Authors:  Lihui Wang; Jinjin Cao; Qianqian Xu; Xiaomei Lu; Xin Yang; Qiong Song; Shuai Chen; Kechen Du; Renbin Huang; Chunlin Zou
Journal:  Front Pharmacol       Date:  2021-12-16       Impact factor: 5.810

Review 7.  Pathophysiological Mechanisms Explaining the Association Between Low Skeletal Muscle Mass and Cognitive Function.

Authors:  Susanne Janette Oudbier; Jorming Goh; Stéphanie Marcella Leonie Maria Looijaard; Esmee Mariëlle Reijnierse; Carolus Gerardus Maria Meskers; Andrea Britta Maier
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-10-06       Impact factor: 6.591

Review 8.  Neuroinflammation in Alzheimer's Disease.

Authors:  Isaac G Onyango; Gretsen V Jauregui; Mária Čarná; James P Bennett; Gorazd B Stokin
Journal:  Biomedicines       Date:  2021-05-07

Review 9.  Metabolic Syndrome: Is It Time to Add the Central Nervous System?

Authors:  Milagros Rojas; Mervin Chávez-Castillo; Daniela Pirela; Heliana Parra; Manuel Nava; Maricarmen Chacín; Lissé Angarita; Roberto Añez; Juan Salazar; Rina Ortiz; Samuel Durán Agüero; Marbel Gravini-Donado; Valmore Bermúdez; Edgar Díaz-Camargo
Journal:  Nutrients       Date:  2021-06-30       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.